5435242022-07-012022-09-305435242022-09-305435242022-03-315435242022-04-012022-09-305435242022-07-012022-09-30in-bse-fin:OtherExpenses1Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses2Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses3Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses4Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses5Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses6Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses7Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses8Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses9Member5435242022-07-012022-09-30in-bse-fin:OtherExpenses10Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses1Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses2Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses3Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses4Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses5Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses6Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses7Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses8Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses9Member5435242022-04-012022-09-30in-bse-fin:OtherExpenses10Member5435242022-07-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15435242022-04-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543524RAINBOWNOTLISTEDINE961O01016Rainbow Children's Medicare LimitedEquity2022-04-012023-03-312022-11-032022-10-26INRMillionsHalf yearlySingle segmentThe business of running multi-specialty pediatric and obstetrics and gynecology hospital.2022-11-0312:30:002022-11-0314:25:00trueCash Flow IndirectNot applicable2022-07-012022-09-30UnauditedStandalone29779000007940000030573000004115900000032456000012495000020818000011919900002261270000796030000-46300000749730000227730000-363600001913700000558360000000055836000011000055847000055847000001015020000105.545.54005.545.54000Notes : <BR> <BR> 1 The standalone financial results of Rainbow Children's Medicare Limited (formerly known as Rainbow Children's Medicare Private Limited) ("the Company") have been prepared in accordance with Indian Accounting Standards ("Ind AS") prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> 2 The above standalone financial results for the quarter and half year ended 30 September 2022 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 03 November 2022 and have been subject to limited review by the statutory auditor of the Company. An unmodified review opinion has been issued by them thereon. <BR> <BR> 3 The standalone figures for the quarter ended 30 September 2021 are the balancing figures between the audited year to date standalone figures up to the second quarter of the previous financial year and the published unaudited year to date standalone figures up to the first quarter of the previous financial year. <BR> 4 During the period, the Board of Directors of the Company in their meeting held on 04 April 2022, approved conversion of (i) 1,146,771 0.0001% Series A Compulsorily Convertible Preference Shares (CCPS) of face value of Rs. 48 each into 1,146,771 Equity Shares of Rs. 10 each and (ii) 1,133,309 0.0001% Series B Compulsorily Convertible Preference Shares of face value of Rs. 48 each into 1,133,309 Equity Shares of Rs. 10 each, at a conversion ratio of 1:1, ranking pair passu with the existing Equity Shares of the Company. <BR> 5 During the period, the Board of Directors of the Company in their meeting held on 08 August 2022, approved the cancellation of unissued authorised share capital of (i) 1,146,771 0.0001% Series A Compulsorily Convertible Preference Shares (CCPS) of face value of Rs. 48 each and (ii) 1,133,309 0.0001% Series B Compulsorily Convertible Preference Shares of face value of Rs. 48 each and increased 10,944,384 Equity Shares of Rs. 10 each amounting to Rs. 109,443,840. The same is approved by the members of the Company in their Annual General Meeting held on 15 September 2022. <BR> <BR> 6 For Note No.6 please refer PDF financial results. <BR> <BR> 7 "The Board of Directors of Rosewalk Healthcare Private Limited (wholly owned subsidiary) ("RHPL") in their meeting held on 27 September 2022, approved the conversion of 729,209 of Compulsory Convertible Debentures (CCD) of face value of Rs.10 each and allotted equivalent number of Equity shares of face value Rs. 10 each to its holding company. Further, 31,000,000 equity shares of face value of Rs.10 each has been allotted on rights basis to its holding company. The total investment of holding company in Rosewalk Healthcare Private limited as at 30 September 2022 is Rs. 324.11 million (before impairment loss). Management has carried out an impairment evaluation as at reporting date and has recognised Rs.46.30 million as an impairment loss on investment. With aforesaid proceeds RHPL has repaid borrowings including interest of Rs. 312.67 million to its holding Company." <BR> <BR> 8 The Company is primarily engaged in the business of rendering medical and healthcare services which is the only reportable business segment as per INDAS 108 - 'Operating Segments'. <BR> <BR> 9 The standalone financial results for the half year ended 30 September 2022, are available on the BSE Limited website (URL: www.bseindia.com), the National Stock Exchange of India Limited website (URL: www.nseindia.com) and on the company's website (URL: www.rainbowhospitals.in). <BR> <BR> <BR> 2022-04-012022-09-30UnauditedStandalone5205430000143470000534890000070844000000611790000259240000411130000206085000040514500001297450000-463000001251150000377860000-6102000031684000009343100000000934310000487000093918000093918000001015020000109.269.26009.269.26000Professional fees to doctors667530000Canteen expenses45080000Contract wages60860000Housekeeping expenses17420000Power and fuel51490000Lab and investigations28030000Repairs and maintenance89630000Rates and taxes18610000Business promotion and advertisement65060000Other Expenses148280000Professional fees to doctors1191180000Canteen expenses82530000Contract wages110140000Housekeeping expenses33000000Power and fuel96720000Lab and investigations51270000Repairs and maintenance133100000Rates and taxes36440000Business promotion and advertisement100700000Other Expenses225770000832769000027219000000237200002880000004654400000511110000270865000036852000001744400001760900001266221000019043000040000631640000117924000013853300007600003613000032331400000890500003512620000161748300001015020000872320000097382200009738220000005192260000519226000055610000000524787000007177400003252300001042970000105500000160300002424000001188740000643661000016174830000259240000-58390000-2555100000000931900000126430000000411130000000-7510000012000001950000000000-446000000523230000177438000000035318000001421200000000310000000000028800005822500000000000000000113500002462500000019500001141200000-1530250000-20686500000028000100000000003981100002640500000225300000277100000-1386000001746240000109879000001098790000804500001179240000Re-measurement gain on defined benefit plans150000150000Re-measurement gain on defined benefit plans6510000651000040000164000000